AstraZeneca plc ADR (AZN)


AstraZeneca is a prescription-based biopharmaceutical company. Co. discovers, develops and commercializes prescription medicines for six areas of healthcare: Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology and Respiratory and Inflammation. Co. maintains a range of products which includes a number of key products such as: Arimidex (for breast cancer), Crestor (for managing cholesterol levels), Nexium (for acid reflux), Seroquel (for schizophrenia and bipolar disorder), Synagis (for RSV, a respiratory infection in infants) and Symbicort (for asthma and chronic obstructive pulmonary disease). Co. is active in over 100 countries.

Filers who had this stock in their top 10: 3
13F Filers holding this stock: 360
Aggregate shares on 09/30/2015: 205,162,278
Aggregate shares on 06/30/2015: 195,474,354
Percent change: 4.96%
Funds creating new positions: 32
Funds Adding to an existing position: 123
Funds closing out their position: 32
Funds reducing their position: 128

13F Filers holding this stock

Quarter 1: Refresh

Changes in Holdings:

*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Schedule 13D and 13G filings submitted since 09/30/2015

Subscription required

    Stock Split History:
  • 07/27/2015: 2:1

Elevate your investments